Meglumine antimoniate - Misplaced Pages

This is an old revision of this page, as edited by 205.232.183.66 (talk) at 20:31, 27 January 2012. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 20:31, 27 January 2012 by 205.232.183.66 (talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Meglumine antimoniate" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Meglumine antimoniate
Clinical data

AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	P01CB01 (WHO) QP51AB01 (WHO)
Identifiers
IUPAC name Hydroxy-dioxostiborane; (2R,3R,4R,5S)-6-methylaminohexane-1,2,3,4,5-pentol
CAS Number	133-51-7
PubChem CID	64953
ChemSpider	58479
ChEMBL	ChEMBL239129
NIAID ChemDB	008733
CompTox Dashboard (EPA)	DTXSID4043935
ECHA InfoCard	100.004.645
Chemical and physical data
Formula	Variable
Molar mass	Variable
3D model (JSmol)	Interactive image
SMILES O=(=O)O.O((O)(O)(O)CNC)CO
InChI InChI=1S/C7H17NO5.H2O.2O.Sb/c1-8-2-4(10)6(12)7(13)5(11)3-9;;;;/h4-13H,2-3H2,1H3;1H2;;;/q;;;;+1/p-1/t4-,5+,6+,7+;;;;/m0..../s1 Key:XOGYVDXPYVPAAQ-SESJOKTNSA-M
(what is this?) (verify)

Meglumine antimoniate (or meglumine antimonate) is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy. It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.

See also